BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bridges MD, St. Amant BS, Mcneil RB, Cernigliaro JG, Dwyer JP, Fitzpatrick PM. High-Dose Gadodiamide for Catheter Angiography and CT in Patients With Varying Degrees of Renal Insufficiency: Prevalence of Subsequent Nephrogenic Systemic Fibrosis and Decline in Renal Function. American Journal of Roentgenology 2009;192:1538-43. [DOI: 10.2214/ajr.07.3895] [Cited by in Crossref: 23] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Louie A. Multimodality imaging probes: design and challenges. Chem Rev 2010;110:3146-95. [PMID: 20225900 DOI: 10.1021/cr9003538] [Cited by in Crossref: 789] [Cited by in F6Publishing: 713] [Article Influence: 71.7] [Reference Citation Analysis]
2 Sena BF, Stern JP, Pandharipande PV, Klemm B, Bulman J, Pedrosa I, Rofsky NM. Screening Patients to Assess Renal Function Before Administering Gadolinium Chelates: Assessment of the Choyke Questionnaire. American Journal of Roentgenology 2010;195:424-8. [DOI: 10.2214/ajr.09.3803] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
3 Inoue A, Tagawa M, Kumon Y, Watanabe H, Ohue S, Ohtsuka Y, Nakamura Y, Ohnishi T. Usefulness of the fusion imaging of 3D-CT and MRA for carotid artery stenting with minimum use of contrast medium in patient with renal dysfunction. Interv Neuroradiol 2015;21:277-81. [PMID: 25934657 DOI: 10.1177/1591019915581941] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
4 Mustafi D, Gleber SC, Ward J, Dougherty U, Zamora M, Markiewicz E, Binder DC, Antic T, Vogt S, Karczmar GS, Oto A. IV Administered Gadodiamide Enters the Lumen of the Prostatic Glands: X-Ray Fluorescence Microscopy Examination of a Mouse Model. AJR Am J Roentgenol 2015;205:W313-9. [PMID: 26295667 DOI: 10.2214/AJR.14.14055] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 Takehara Y, Yamashita S, Sakahara H, Masui T, Isoda H. Magnetic resonance angiography of the aorta. Ann Vasc Dis 2011;4:271-85. [PMID: 23555465 DOI: 10.3400/avd.di.11.00822] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
6 Zou Z, Ma L. Nephrogenic systemic fibrosis: review of 408 biopsy-confirmed cases. Indian J Dermatol. 2011;56:65-73. [PMID: 21572796 DOI: 10.4103/0019-5154.77556] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
7 Hodnett PA, Ward EV, Davarpanah AH, Scanlon TG, Collins JD, Glielmi CB, Bi X, Koktzoglou I, Gupta N, Carr JC. Peripheral arterial disease in a symptomatic diabetic population: prospective comparison of rapid unenhanced MR angiography (MRA) with contrast-enhanced MRA. AJR Am J Roentgenol. 2011;197:1466-1473. [PMID: 22109304 DOI: 10.2214/ajr.10.6091] [Cited by in Crossref: 45] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
8 Thierfelder KM, Meimarakis G, Nikolaou K, Sommer WH, Schmitt P, Kazmierczak PM, Reiser MF, Theisen D. Non-contrast-enhanced MR angiography at 3 Tesla in patients with advanced peripheral arterial occlusive disease. PLoS One 2014;9:e91078. [PMID: 24608937 DOI: 10.1371/journal.pone.0091078] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]